Prologue Medicines
Prologue is systematically discovering the therapeutic potential of secreted proteins tuned through millennia of natural evolution to rapidly create powerful new medicines.
$50M ·
Source: fundraisingfox.com
Funding history ↓Signals
Prologue Medicines | 356 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Round · $50MSource: fundraisingfox.com
- X account created
- Website created
Founders and team
HB
LA
Lovisa Afzelius FounderNA
Noubar Afeyan FounderTA
Theonie Anastassiadis Founding President
Investors
Companies like Prologue Medicines
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
YYolTech Therapeutics$45M Series B+ · Sep 2025
AAtavistik Bio$40M Series B+ · Mar 2026
TTubulis$360M Series B+ · Oct 2025
OOutrun TherapeuticsSeed · Apr 2024
CCamp4Series B+ · Jul 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/prologue-medicines (get a free API key).